Skip to main content
Premium Trial:

Request an Annual Quote

'Pharma Bro' Out of Prison

Martin Shkreli, the so-called "Pharma Bro," has been released from prison, the Wall Street Journal reports.

It adds that Shkreli was convicted in 2017 on federal securities fraud charges related to two hedge funds and a company he founded. According to Politico, Shkreli was sentenced to seven years for lying to investors about how those hedge funds were performing, taking money from those funds, and defrauding investors in the drug company Retrophin by obscuring his ownership share.

Shkreli was also widely condemned for buying the rights to the antiparasitic drug Daraprim and raising the price from $13.50 to $750 a pill, Politico notes. The Journal adds that Shkreli further gained notoriety for paying $2 million for the only copy of a Wu-Tang Clan album; the US government sold it last July to cover the $7.4 million in forfeiture Shkreli was also ordered to pay.

Shkreli, according to the Journal, has been transferred to a halfway house and is expected to be released from federal custody in September.

Filed under

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.